Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

The Silicon Review explores how skipping routine dental checkups can lead to costly treatments, poor health outcomes, and ...

Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, ...

A 52-year-old man presented to our orthopedic clinic with an 8-month history of a right distal forearm mass accompanied by ...

Women with advanced breast cancer who undergo breast cancer surgery may live longer than those who don't have surgery, a new ...

Lolo Lekgoane’s life changed when she was diagnosed with systemic lupus erythematosus. The Mahikeng resident faced immense challenges, including giving up her job, losing mobility and enduring ...

During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...

Using OCT to look at the burden, not just individual factors, helps provide clues on why disease develops—and how it ...

Rates of Raynaud phenomenon medication initiation are low among patients with SSc in the United States, with less than one-third receiving consistent treatment.

During a live event, Nelson J. Chao, MD, asked participants how they employ the currently approved treatments for chronic GVHD.

Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the promotion of Sanam Pangali to ...

Pierre Fabre Laboratories have received marketing authorisation in China for BRAFTOVI (encorafenib) in combination with ...